A Study of Single and Multiple Ascending Doses of VIB1116 in Rheumatic Diseases

NCT04948099 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Dendritic Cell -Mediated Rheumatic Diseases

Interventions

DRUG: VIB1116
DRUG: Placebo

Sponsor

Amgen